Replies to post #251218 on Biotech Values

[DewDiligence]

JNJ acquires SWAV for $335/sh cash—a 17% premium to SWAV’s “unaffected” share price on 3/25/24:

https://finance.yahoo.com/news/johnson-johnson-acquire-shockwave-medical-103100477.html

The nominal deal value is $12.5B (net of SWAV’s cash on hand).

[DewDiligence]

ABT pursues IVL market pioneered by Shockwave Medical:

https://finance.yahoo.com/news/abbott-initiates-intravascular-lithotripsy-clinical-130000821.html